{
      "date": "2026-02-14",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/52602",
      "id_number": "oai:ojs2.journal.urdti.uz:article/309",
      "type": "article",
      "full_text_status": "none",
      "official_url": "http://journal.urdti.uz/index/article/view/309",
      "subjects": [
        "polifarmatsiya",
        "dori\u2013dori o\u2018zaro ta\u2019siri",
        "nojo\u2018ya dori reaksiyasi",
        "dori xavfsizligi",
        "medication reconciliation"
      ],
      "userid": 1,
      "note": "Imported from URDTI Journal (OAI id oai:ojs2.journal.urdti.uz:article/309)",
      "ispublished": "pub",
      "metadata_visibility": "show",
      "date_type": "published",
      "rev_number": 1,
      "datestamp": "2026-05-26 15:45:44",
      "publisher": "South Aral Region Medical Journal",
      "publication": "South Aral Region Medical Journal",
      "lastmod": "2026-05-26 15:45:44",
      "eprint_status": "archive",
      "keywords": "polifarmatsiya; dori\u2013dori o\u2018zaro ta\u2019siri; nojo\u2018ya dori reaksiyasi; dori xavfsizligi; medication reconciliation",
      "sword_depositor": 1,
      "dir": "disk0/00/05/26/02",
      "creators": [
        {
          "name": {
            "lineage": null,
            "family": "Qurbonova",
            "given": "Gulnoza",
            "honourific": null
          }
        },
        {
          "name": {
            "honourific": null,
            "given": "Maxfirat",
            "family": "Kibriyeva",
            "lineage": null
          }
        }
      ],
      "eprintid": 52602,
      "status_changed": "2026-05-26 15:45:44",
      "title": "POLIFARMATSIYA VA DORI\u2013DORI O\u2018ZARO TA\u2019SIRLARI: KLINIK XAVFLAR, PROFILAKTIKA VA DORI KO\u2018RIB CHIQISH (MEDICATION REVIEW) ALGORITMLARI",
      "abstract": "Polifarmatsiya (odatda 5 va undan ortiq dori vositasini bir vaqtda qabul qilish) ko\u2018p kasallikli bemorlarda klinik natijalarni yaxshilashi mumkin, biroq u dori\u2013dori o\u2018zaro ta\u2019sirlari (DDI), nojo\u2018ya dori reaksiyalari, dori xatolari, adherens pasayishi hamda davolash xarajatlarining ortishi bilan bog\u2018liq xavflarni sezilarli oshiradi. Ayniqsa, keksa yosh, buyrak/jigar funksiyasi pasayishi, tor terapevtik oraliqli preparatlar (antikoagulyantlar, antiaritmiklar va boshqalar) qabul qilinishi hamda OTC/fitopreparatlar qo\u2018shilishi klinik ahamiyatli DDI ehtimolini kuchaytiradi. Ushbu tahliliy maqolada polifarmatsiyaning asosiy sabablari va \u201co\u2018rinli\u201d hamda \u201cmuammoli\u201d polifarmatsiya tushunchalari yoritiladi; farmakokinetik (CYP fermentlari, P-gp, absorbsiya va eliminatsiya o\u2018zgarishi) va farmakodinamik (qon ketish, giperkalemiya, sedatsiya/yiqilish, QT oralig\u2018i uzayishi) o\u2018zaro ta\u2019sir mexanizmlari tizimlashtiriladi. Shuningdek, xavfni kamaytirish uchun dori yarashtirish (medication reconciliation), strukturali dori ko\u2018rib chiqish (medication review), skrining mezonlari (Beers, STOPP/START) hamda \u201cAvoid\u2013Adjust\u2013Monitor\u201d tamoyiliga asoslangan amaliy boshqaruv algoritmi taklif etiladi. Maqola yakunida individual depreskribing yondashuvi va monitoring orqali polifarmatsiya xavfsizligini oshirish bo\u2018yicha tavsiyalar beriladi"
    }